BetterLife Pharma (BETRF) Depreciation and Depletion (2011 - 2016)
BetterLife Pharma (BETRF) posted quarterly Depreciation and Depletion of $49725.0 for Q1 2016, up 50623.68% year-over-year from N/an in Q1 2015, and up 57810.68% quarter-over-quarter from $85.86 in Q4 2015.
BetterLife Pharma (BETRF) Depreciation and Depletion (2011 - 2016) Analysis & Trends
BetterLife Pharma's Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $49725.0 for Q1 2016.
- In Q1 2016, Depreciation and Depletion rose 50623.68% year-over-year to $49725.0; the TTM figure through Jan 2016 stood at $49993.7 (up 12128.09% YoY), while the FY2016 annual figure was $322.0, down 21.27% from the prior year.
- Depreciation and Depletion for Q1 2016 stood at $49725.0, up from $85.86 in the prior quarter.
- The five-year high for Depreciation and Depletion was $664231.0 in Q1 2012, with the low at -$647079.0 in Q2 2012.
- The 5-year median for Depreciation and Depletion is $100.17 (2014), against an average of $7175.7.
- The sharpest annual moves came in 2014 and 2016: Depreciation and Depletion tumbled 98.06% in 2014, then soared 50623.68% in 2016.
- BetterLife Pharma's Depreciation and Depletion stood at -$12493.0 in 2012, then plunged by 56.94% to -$19606.0 in 2013, then jumped by 100.52% to $102.3 in 2014, then dropped by 16.07% to $85.86 in 2015, then jumped by 57810.68% to $49725.0 in 2016.
- Business Quant data shows BETRF's Depreciation and Depletion at $49725.0 in Q1 2016, $85.86 in Q4 2015, and $91.6 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2016 | 49,725.00 |
| Jan 31, 2016 | 49,725.00 |
| Oct 31, 2015 | 85.86 |
| Oct 31, 2015 | 85.86 |
| Jul 31, 2015 | 91.60 |
| Jul 31, 2015 | 91.60 |
| Apr 30, 2015 | 91.26 |
| Apr 30, 2015 | 91.26 |
| Jan 31, 2015 | 98.03 |
| Jan 31, 2015 | 98.03 |
| Oct 31, 2014 | 102.30 |
| Oct 31, 2014 | 102.30 |
| Jul 31, 2014 | 105.39 |
| Jul 31, 2014 | 105.39 |
| Apr 30, 2014 | 103.12 |
| Apr 30, 2014 | 103.12 |
| Oct 31, 2013 | -19,606.00 |
| Oct 31, 2013 | -19,606.00 |
| Jul 31, 2013 | 5,423.00 |
| Jul 31, 2013 | 5,423.00 |